| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Womens Health Research Institute, Wyeth-Ayerst Research, Radnor, Pennsylvania 19087
Address all correspondence and requests for reprints to: Dr. Susan L. Fitzpatrick, Womens Health Research Institute, Wyeth-Ayerst Research, 145 King of Prussia Road, Radnor, Pennsylvania 19087. E-mail: fitzpas2{at}war.wyeth.com
Estrogen is essential in the hypothalamus for the central regulation of
reproduction. To understand the molecular mechanism(s) of estrogen
action in the hypothalamus, immortalized rat embryonic hypothalamic
cell lines were characterized for steroid receptors and subcloned.
Scatchard analysis of the D12 subclone demonstrated one high affinity
estrogen receptor-binding site (Kd = 31.3 ± 1.9
pM) with a Bmax of 30.8 ± 0.8 fmol/mg.
Estrogen receptor-
protein was identified by Western blot and gel
shift analyses. Treatment with estradiol (48 h) stimulated progesterone
receptor (PR) messenger RNA expression and binding to
[3H]R5020, a synthetic progestin. Because the agonist or
antagonist activity of estrogen mimetics can be cell type dependent,
the activities of various estrogen mimetics were determined in D12
cells. ICI 182,780 (IC50 = 0.63 nM),
raloxifene (IC50 = 1 nM), enclomiphene
(IC50 = 77 nM), and tamoxifen
(IC50 = 174 nM) inhibited the induction of
PR by estradiol, and none of these compounds significantly stimulated
PR when given alone. In contrast, 17
-ethynyl estradiol
(EC50 = 0.014 nM), zuclomiphene
(EC50 = 100 nM), and genistein
(EC50 = 17.5 nM) functioned as estrogen
agonists in these cells. In addition, the estrogen-induced progesterone
receptor activated a progesterone response element reporter construct
in response to progestins. Thus, the D12 rat hypothalamic cell line
provides a useful model for characterizing tissue-selective estrogenic
compounds, identifying estrogen- and progesterone-regulated
hypothalamic genes, and understanding the molecular mechanisms of
steroid action in various physiological processes mediated by the
hypothalamus.
This article has been cited by other articles:
![]() |
J. A. Arreguin-Arevalo and T. M. Nett A Nongenomic Action of 17{beta}-Estradiol as the Mechanism Underlying the Acute Suppression of Secretion of Luteinizing Hormone Biol Reprod, July 1, 2005; 73(1): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, K. S. Knappenberger, H. Kack, G. Andersson, E. Nilsson, C. Dartsch, and C. W. Scott A Homogeneous in Vitro Functional Assay for Estrogen Receptors: Coactivator Recruitment Mol. Endocrinol., March 1, 2003; 17(3): 346 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pavan, C. Biondi, M. E. Ferretti, L. Lunghi, and G. Paganetto 17{beta}-Estradiol Modulates Prostaglandin E2 Release from Human Amnion-Derived WISH Cells Biol Reprod, June 1, 2001; 64(6): 1677 - 1681. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |